MiR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3.

Autor: Yu, Ling1 (AUTHOR), Li, Haiting1 (AUTHOR), Liu, Wenhu1 (AUTHOR), Zhang, Ligong1 (AUTHOR), Tian, Qun1 (AUTHOR), Li, Hairong1 (AUTHOR), Li, Min1 (AUTHOR) minli_neurology@163.com
Zdroj: Molecular Genetics & Genomic Medicine. Jan2021, Vol. 9 Issue 1, p1-9. 9p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje